Literature DB >> 1521043

Tobacco-specific nitrosamines--metabolism and biological monitoring of exposure to tobacco products.

E Richter1, G Schäffler, A Malone, J Schulze.   

Abstract

Tobacco-specific nitrosamines are derived from nicotine and related tobacco alkaloids and can be detected in tobacco products as well as in mainstream and sidestream smoke. Two of them, N-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, are strong carcinogens in laboratory animals. Because of its organospecificity for the lung, the latter is considered to be a causative factor in tobacco-related human lung cancer. Upon metabolic activation both nitrosamines give rise to a common reactive intermediate binding to macromolecules such as DNA and haemoglobin and hydrolysing to 4-hydroxy-1-(3-pyridyl)-1-butanone. Because of easy access to large quantities of haemoglobin from blood samples, it is most suitable for biomonitoring human exposure to tobacco-specific nitrosamines. A highly sensitive analytical method for determination of femtogram amounts of 4-hydroxy-1-(3-pyridyl)-1-butanone provides an approach to assess individual exposure to active and passive smoking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521043     DOI: 10.1007/bf00184664

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  18 in total

Review 1.  Protein adducts in the molecular dosimetry of chemical carcinogens.

Authors:  P L Skipper; S R Tannenbaum
Journal:  Carcinogenesis       Date:  1990-04       Impact factor: 4.944

2.  Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes.

Authors:  J D Adams; K J O'Mara-Adams; D Hoffmann
Journal:  Carcinogenesis       Date:  1987-05       Impact factor: 4.944

3.  Dietary modification of intestinal and pulmonary aryl hydrocarbon hydroxylase activity.

Authors:  L W Wattenberg
Journal:  Toxicol Appl Pharmacol       Date:  1972-12       Impact factor: 4.219

Review 4.  Alkylation of macromolecules for detecting mutagenic agents.

Authors:  L Ehrenberg; S Osterman-Golkar
Journal:  Teratog Carcinog Mutagen       Date:  1980

Review 5.  Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.

Authors:  D Hoffmann; S S Hecht
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

6.  Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.

Authors:  A Rivenson; D Hoffmann; B Prokopczyk; S Amin; S S Hecht
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

7.  Identification and analysis of a new tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanol.

Authors:  K D Brunnemann; L Genoble; D Hoffmann
Journal:  Carcinogenesis       Date:  1987-03       Impact factor: 4.944

8.  Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine.

Authors:  S S Hecht; N Trushin; A Castonguay; A Rivenson
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

9.  Effects of alpha-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats.

Authors:  S S Hecht; D Lin; A Castonguay; A Rivenson
Journal:  Carcinogenesis       Date:  1987-02       Impact factor: 4.944

Review 10.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

Authors:  S S Hecht; D Hoffmann
Journal:  Carcinogenesis       Date:  1988-06       Impact factor: 4.944

View more
  2 in total

1.  Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines.

Authors:  B Falter; C Kutzer; E Richter
Journal:  Clin Investig       Date:  1994-05

2.  Passive smoking as a risk factor of anemia in young children aged 0-35 months in Jordan.

Authors:  Rathavuth Hong; Jose A Betancourt; Martin Ruiz-Beltran
Journal:  BMC Pediatr       Date:  2007-04-10       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.